Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...
Our Bureau, Mumbai Tuesday, March 18, 2025, 16:30 Hrs [IST] ...
After Hiding My Undiagnosed Neurological Condition for Decades, I Finally Found Answers A personal quest and progress in brain science finally put a name on baffling behaviors ...
IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...
From ‘Envy, inequality and fertility’ to ‘Market size, trade and productivity’, using catchy three-part phrases in the titles of research papers can boost their citations, suggests a study.
Sequana Medical NV: Press release: Sequana Medical announces 2024 Full Year Results and 2025 Outlook
Sequana Medical announces 2024 Full Year Results and 2025 Outlook alfapump® - US FDA approval of alfapump® for the treatment of recurrent or refractory ascites due to liver cirrhosis; US commercial ...
On 3 April 2024, the Company announced publication of the results of the RED DESERT and SAHARA proof-of-concept studies, in the prestigious peer-reviewed journal European Journal of Heart Failure.
Although their approaches diverged, Corita Kent and Andy Warhol were central figures in the 1960s Pop Art movement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results